$20.13
Insights on Modivcare Inc
Revenue is up for the last 2 quarters, 686.92M → 702.83M (in $), with an average increase of 2.3% per quarter
Netprofit is down for the last 2 quarters, -4.30M → -5.25M (in $), with an average decrease of 22.1% per quarter
In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 125.9%
In the last 3 years, Tenet Healthcare Corp. has given 12.8% return, outperforming this stock by 98.2%
1.39%
Downside
Day's Volatility :5.01%
Upside
3.67%
0.0%
Downside
52 Weeks Volatility :73.98%
Upside
73.98%
Period | Modivcare Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -46.69% | -0.7% | 0.0% |
6 Months | -48.31% | 6.6% | 0.0% |
1 Year | -73.01% | 3.7% | -1.5% |
3 Years | -84.72% | 14.0% | -21.8% |
Market Capitalization | 310.1M |
Book Value | $11.0 |
Earnings Per Share (EPS) | -14.43 |
PEG Ratio | 1.42 |
Wall Street Target Price | 46.6 |
Profit Margin | -7.43% |
Operating Margin TTM | 2.18% |
Return On Assets TTM | 1.28% |
Return On Equity TTM | -80.06% |
Revenue TTM | 2.8B |
Revenue Per Share TTM | 194.1 |
Quarterly Revenue Growth YOY | 7.5% |
Gross Profit TTM | 472.3M |
EBITDA | 142.4M |
Diluted Eps TTM | -14.43 |
Quarterly Earnings Growth YOY | -0.75 |
EPS Estimate Current Year | 4.3 |
EPS Estimate Next Year | 5.74 |
EPS Estimate Current Quarter | 1.28 |
EPS Estimate Next Quarter | 1.32 |
What analysts predicted
Upside of 131.5%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↓ 14.71% |
Net Income | -19.0M | ↓ 135.57% |
Net Profit Margin | -1.37% | ↓ 4.66% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.5B | ↑ 9.02% |
Net Income | -5.0M | ↓ 73.91% |
Net Profit Margin | -0.33% | ↑ 1.04% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↓ 9.36% |
Net Income | 88.8M | ↓ 1893.58% |
Net Profit Margin | 6.49% | ↑ 6.82% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.0B | ↑ 45.9% |
Net Income | 32.0M | ↓ 64.02% |
Net Profit Margin | 1.6% | ↓ 4.89% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.5B | ↑ 25.41% |
Net Income | -1.8M | ↓ 105.76% |
Net Profit Margin | -0.07% | ↓ 1.67% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 2.8B | ↑ 9.85% |
Net Income | -204.5M | ↑ 10999.89% |
Net Profit Margin | -7.43% | ↓ 7.36% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 647.8M | ↑ 3.11% |
Net Income | -2.1M | ↓ 138.21% |
Net Profit Margin | -0.32% | ↓ 1.18% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 575.8M | ↓ 11.12% |
Net Income | -31.5M | ↑ 1432.57% |
Net Profit Margin | -5.48% | ↓ 5.16% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 662.3M | ↑ 15.03% |
Net Income | -6.0M | ↓ 81.01% |
Net Profit Margin | -0.9% | ↑ 4.58% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 699.1M | ↑ 5.56% |
Net Income | -190.9M | ↑ 3089.31% |
Net Profit Margin | -27.31% | ↓ 26.41% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 686.9M | ↓ 1.74% |
Net Income | -4.3M | ↓ 97.75% |
Net Profit Margin | -0.63% | ↑ 26.68% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 702.8M | ↑ 2.32% |
Net Income | -5.3M | ↑ 22.08% |
Net Profit Margin | -0.75% | ↓ 0.12% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 572.2M | ↓ 18.73% |
Total Liabilities | 183.9M | ↓ 36.72% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 597.4M | ↑ 4.39% |
Total Liabilities | 202.7M | ↑ 10.23% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.4B | ↑ 138.69% |
Total Liabilities | 1.0B | ↑ 400.47% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.0B | ↑ 42.18% |
Total Liabilities | 1.7B | ↑ 63.08% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.9B | ↓ 4.1% |
Total Liabilities | 1.6B | ↓ 3.9% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.8B | ↓ 9.1% |
Total Liabilities | 1.6B | ↑ 1.34% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.0B | ↓ 3.39% |
Total Liabilities | 1.6B | ↓ 2.5% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.9B | ↓ 2.29% |
Total Liabilities | 1.6B | ↓ 2.81% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.9B | ↓ 0.14% |
Total Liabilities | 1.6B | ↑ 0.04% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↓ 8.06% |
Total Liabilities | 1.6B | ↑ 2.08% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↓ 1.23% |
Total Liabilities | 1.6B | ↓ 1.19% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.8B | ↑ 0.24% |
Total Liabilities | 1.6B | ↑ 0.43% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 7.9M | ↓ 85.65% |
Investing Cash Flow | -45.3M | ↓ 5667.81% |
Financing Cash Flow | -51.6M | ↑ 52.58% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 60.9M | ↑ 671.49% |
Investing Cash Flow | -10.9M | ↓ 76.04% |
Financing Cash Flow | -776.0K | ↓ 98.49% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 348.4M | ↑ 471.77% |
Investing Cash Flow | -635.0M | ↑ 5748.33% |
Financing Cash Flow | 408.3M | ↓ 52710.82% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 186.8M | ↓ 46.38% |
Investing Cash Flow | -685.6M | ↑ 7.97% |
Financing Cash Flow | 448.9M | ↑ 9.94% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -10.4M | ↓ 105.59% |
Investing Cash Flow | -111.8M | ↓ 83.69% |
Financing Cash Flow | 3.8M | ↓ 99.15% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -5.7M | ↓ 68.2% |
Investing Cash Flow | -9.6M | ↓ 88.83% |
Financing Cash Flow | 57.0K | ↓ 102.33% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -56.0M | ↑ 885.35% |
Investing Cash Flow | -7.4M | ↓ 22.92% |
Financing Cash Flow | 5.6M | ↑ 9785.96% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.7M | ↓ 95.26% |
Investing Cash Flow | -13.3M | ↑ 79.44% |
Financing Cash Flow | 14.4M | ↑ 155.19% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -108.2M | ↑ 3976.05% |
Investing Cash Flow | -8.9M | ↓ 32.85% |
Financing Cash Flow | 111.3M | ↑ 673.64% |
Sell
Neutral
Buy
Modivcare Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Modivcare Inc | -29.44% | -48.31% | -73.01% | -84.72% | -87.25% |
Fresenius Medical Care Ag | -0.32% | 10.42% | -15.35% | -50.85% | -51.82% |
Hca Holdings, Inc. | -4.93% | 28.25% | 14.58% | 59.59% | 169.9% |
Tenet Healthcare Corp. | -4.36% | 72.26% | 44.71% | 82.68% | 310.08% |
Universal Health Services Inc. | -9.74% | 24.99% | 16.98% | 9.58% | 28.53% |
Davita Healthcare Partners Inc. | -6.85% | 62.1% | 52.88% | 15.22% | 144.38% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Modivcare Inc | NA | NA | 1.42 | 4.3 | -0.8 | 0.01 | NA | 11.0 |
Fresenius Medical Care Ag | 20.44 | 20.44 | 0.39 | 2.04 | 0.05 | 0.03 | 0.03 | 46.42 |
Hca Holdings, Inc. | 17.0 | 17.0 | 1.44 | 20.64 | 0.12 | 0.11 | 0.01 | -6.68 |
Tenet Healthcare Corp. | 17.21 | 17.21 | 2.2 | 6.03 | 0.26 | 0.06 | NA | 16.09 |
Universal Health Services Inc. | 16.27 | 16.27 | 1.87 | 13.45 | 0.12 | 0.05 | 0.0 | 91.53 |
Davita Healthcare Partners Inc. | 17.49 | 17.49 | 1.16 | 9.01 | 0.39 | 0.06 | NA | 11.89 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Modivcare Inc | Buy | $310.1M | -87.25% | NA | -7.43% |
Fresenius Medical Care Ag | Hold | $10.9B | -51.82% | 20.44 | 2.57% |
Hca Holdings, Inc. | Buy | $85.3B | 169.9% | 17.0 | 8.07% |
Tenet Healthcare Corp. | Buy | $9.7B | 310.08% | 17.21 | 2.97% |
Universal Health Services Inc. | Hold | $11.2B | 28.53% | 16.27 | 5.03% |
Davita Healthcare Partners Inc. | Hold | $11.3B | 144.38% | 17.49 | 5.7% |
Coliseum Capital Management LLC
BlackRock Inc
Vanguard Group Inc
Neuberger Berman Group LLC
Fuller & Thaler Asset Management Inc
Silvercrest Asset Management Group LLC
Modivcare Inc’s price-to-earnings ratio stands at None
Read Moremodivcare is a healthcare services leader. our company was created to address the social determinants of health (sdoh) by providing non-emergency medical transportation (nemt), personal care, nutritious meals, and remote patient monitoring. we provide integrated technologies that support care solutions for payors and their members – leading to greater access to care, reduced costs, and improved outcomes.
Organization | Modivcare Inc |
Employees | 21200 |
CEO | Mr. L. Heath Sampson |
Industry | Healthcare |